<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Dechra launches &amp;#39;breakthrough&amp;#39; mastitis treatment</title><link>/b/veterinary-news/posts/dechra-launches-39-breakthrough-39-mastitis-treatment</link><description> Dechra Animal Health has launched Revozyn RTU, billed as a revolutionary breakthrough for subclinical and clinical local mastitis in cows. 
 Revozyn RTU, which contains 400 mg/ml Penethamate hydriodide, is the first ready-to-use injectable narrow spectrum</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>